These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
773 related items for PubMed ID: 15525714
1. Dose sparing with intradermal injection of influenza vaccine. Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. N Engl J Med; 2004 Nov 25; 351(22):2295-301. PubMed ID: 15525714 [Abstract] [Full Text] [Related]
2. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Vaccine; 2009 Jan 14; 27(3):454-9. PubMed ID: 19022318 [Abstract] [Full Text] [Related]
3. Serum antibody responses after intradermal vaccination against influenza. Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G. N Engl J Med; 2004 Nov 25; 351(22):2286-94. PubMed ID: 15525713 [Abstract] [Full Text] [Related]
4. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination. Sugimura T, Ito Y, Tananari Y, Ozaki Y, Maeno Y, Yamaoka T, Kudo Y. Vaccine; 2008 May 23; 26(22):2700-5. PubMed ID: 18436353 [Abstract] [Full Text] [Related]
5. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. Jo YM, Song JY, Hwang IS, Lee J, Oh SC, Kim JS, Kim SR, Kim WJ, Cheong HJ. J Med Virol; 2009 Apr 23; 81(4):722-7. PubMed ID: 19235853 [Abstract] [Full Text] [Related]
6. Antibody responses after dose-sparing intradermal influenza vaccination. Auewarakul P, Kositanont U, Sornsathapornkul P, Tothong P, Kanyok R, Thongcharoen P. Vaccine; 2007 Jan 08; 25(4):659-63. PubMed ID: 17011678 [Abstract] [Full Text] [Related]
7. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration. Künzi V, Klap JM, Seiberling MK, Herzog C, Hartmann K, Kürsteiner O, Kompier R, Grimaldi R, Goudsmit J. Vaccine; 2009 Jun 02; 27(27):3561-7. PubMed ID: 19464535 [Abstract] [Full Text] [Related]
8. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Chiu SS, Peiris JS, Chan KH, Wong WH, Lau YL. Pediatrics; 2007 Jun 02; 119(6):1076-82. PubMed ID: 17545373 [Abstract] [Full Text] [Related]
11. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P. Vaccine; 2009 Dec 09; 27(52):7304-12. PubMed ID: 19849996 [Abstract] [Full Text] [Related]
20. Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age. Gorse GJ, Falsey AR, Johnson CM, Morrison D, Fried DL, Ervin JE, Greenberg DP, Ozol-Godfrey A, Landolfi V, Tsang PH. Vaccine; 2013 Dec 05; 31(50):6034-40. PubMed ID: 24055306 [Abstract] [Full Text] [Related] Page: [Next] [New Search]